gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
The vaccine primes neoantigen-specific CD8+ T cells, which recognize the neoantigen peptide–MHC I complexes on tumor cells and kill them via perforin/granzyme cytolysis and Fas–FasL–mediated apoptosis.
enzyme_product
Off
epitope
On
variant
On
isoform
Off
hla_specific
On
gated
Off
other_modifier
CD8+ T-cell epitopes presented on HLA-A/B/C; derived from somatic mutations
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06497010
disease_id_num_tar_ref
2603
drug_id_num_tar_ref
6951